Skip to main content
Free Australian shipping for orders over $59
Search icon
My Account
RegisterSign In
  • Media Centre

    Change of reins at Swisse Wellness

    Swisse Logo - Wellness Hub
    Written by Swisse Wellness

    H&H Group has today announced that the Managing Director for Swisse Wellness ANZ, Oliver Horn, has stepped down from the role.

    Laetitia Garnier, H&H Group CEO, addressed the change, saying it was mutually agreed that now is the right time for Oliver to step down.

    “Since joining Swisse in January 2017, Oliver has led the ANZ and US teams with an enthusiasm for the brand, and we are grateful for Oliver’s contribution during his time with us. In particular I would like to recognise the Swisse brand’s successful re-entry into the US market; the launch of Biostime in Australia; and Oliver’s personal drive to build healthier corporate cultures through such initiatives as the ‘Ride-ToWork’ Scheme.

    “Whilst we share with Oliver a passion for Swisse, and both recognise the need to continue to evolve, we have different views on how to advance the brand, and more broadly, the H&H Group (of six brands) in the local markets,” Mrs Garnier said.

    Following consideration by Management, Nick Mann, Director of Sales for Australia and New Zealand, will step into the role of Managing Director, effective 2 September. Mr Mann has been with the Group since September 2017 and is well-placed to strengthen the business strategy.

    “As a global consumer products organisation, we have recognised that we need a renewed focus on our consumer engagement and the way this translates to commercial outcomes. Nick has built strong relationships in the Australian and New Zealand region and is passionate about working with our business customers to drive innovation – product and otherwise - that will deliver to consumer needs,” Mrs Garnier continued.

    “Australia is a core market for our Group, being the home of Swisse and now also carrying our flagship Biostime brand with infant milk formula and our world-leading children’s probiotics. We are also investing in Australia through manufacturing – goats milk formula production commenced in August – as well as a minority acquisition of Bod Australia through our corporate venture arm NewH2. We feel very confident in Nick leading the business in this key region.

    Mr Mann responded to his appointment, saying: “I am delighted to assume this role to lead the organisation into its next phase. Swisse has a rich 50-year history in ANZ – one of innovation, energy and quality – and we are excited to be reinvigorating these core elements of our DNA for the future.

    “I am committed to continuing the strong investment in our brands, internally through our renowned team culture and externally in the market, and to further aligning our Swisse and Biostime operations with our sustainability focus.

    “As the H&H Group, we are really just starting our journey in this region and we have a great opportunity to look forward - at all our brands and investments - and shape the future of the Group in ANZ by building on the strong relationships we have with customers and suppliers. I am excited at the prospect of introducing more of our brands into the region and commercialising elements of the NewH2 ventures,” Mr Mann concluded.

    For media enquiries, contact:

    Sarah Chibnall, Group Director, Communications

    [email protected] +61 423 762 676